Analyze Diet
The Journal of veterinary medical science2020; 82(9); 1299-1305; doi: 10.1292/jvms.20-0056

Period of excretion of equine herpesvirus 3 (EHV-3) from a stallion before showing clinical signs of equine coital exanthema and the effect of acyclovir treatment on the duration of EHV-3 excretion.

Abstract: In 2017, two Thoroughbred stallions, A and B in Farms A and B, respectively, in Hokkaido in Japan showed clinical signs of equine coital exanthema (ECE). In 2020, stallion C in Farm B showed clinical signs of ECE. Eighteen mares were mated within five days before stallion A developed ECE. Ten mares that mated within 3 days before onset showed clinical signs of ECE on the external genitalia. Equine herpesvirus 3 (EHV-3) was isolated from vaginal swabs from three mares that mated within 2 days before onset. Swabs from 12 mares that mated within 4 days before onset were real-time PCR (rPCR)-positive and nine of those mares had an increased EHV-3 antibody titer. The three stallions were administered valaciclovir orally and topical acyclovir ointment was applied. Treatment started on the next day after onset in stallion A and on the day of onset in stallions B and C. EHV-3 was firstly isolated from penis swabs of stallions A and B before treatment and from penis swabs of stallion C 2 days after treatment. EHV-3 was not isolated after 8, 5 and 8 days from onset in stallions A, B and C, respectively. However, swabs were rPCR-positive for at least 12, 9 and 15 days after onset of stallions A, B and C, respectively. EHV-3 was excreted from the stallions at least within 4 days before the onset of ECE, and acyclovir treatment resulted in the termination of excretion within 8 days after onset.
Publication Date: 2020-07-20 PubMed ID: 32684614PubMed Central: PMC7538329DOI: 10.1292/jvms.20-0056Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The study investigates the excretion period of equine herpesvirus 3 (EHV-3) in stallions before they show symptoms of equine coital exanthema (ECE). The research also evaluates the impact of acyclovir treatment on the duration of EHV-3 excretion.

Objective and Experimental Setup

  • The research was designed to understand the period during which EHV-3, the herpesvirus responsible for ECE in horses, is excreted by stallions prior to the appearance of clinical ECE symptoms. Further, the study explored the effect of acyclovir treatment in altering the duration of virus excretion.
  • Two Thoroughbred stallions, coded as A and B, located in separate farms in Hokkaido, Japan in 2017, and another stallion, coded as C, located in farm B in 2020, became the subjects of the study after showing ECE symptoms.

Observations and Findings

  • Eighteen mares that had mated with stallion A within five days before the appearance of ECE symptoms were monitored and studied. Among them, ten mares developed ECE symptoms after mating within three days before onset.
  • EHV-3 was isolated from the vaginal swabs of three mares that mated with Stallion A within 2 days before ECE signs were evident.
  • Twelve mares that mated within four days before symptoms started showing tested positive for EHV-3 through real-time PCR test. Nine of these twelve mares also exhibited increased EHV-3 antibody levels, suggesting infection.

Treatment and Results

  • All three stallions (A, B, and C) received oral valaciclovir and topical acyclovir ointment. The treatment started the very next day after symptoms appeared in Stallion A, and on the very day of symptom onset in Stallions B and C.
  • EHV-3 was first isolated from the penis swabs of Stallions A and B before treatment and from Stallion C two days after treatment commenced. Following this, EHV-3 could not be identified after 8, 5, and 8 days from onset in stallions A, B, C, respectively.
  • However, swab tests stayed positive for EHV-3 for at least 12, 9, and 15 days after onset in stallions A, B, and C, respectively. This suggests that even after the virus could not be isolated, traces of it remained for several more days.
  • The findings indicated that EHV-3 is excreted by the Stallions at least four days prior to the onset of ECE. Furthermore, the administration of acyclovir would halt the excretion within 8 days after onset.

Cite This Article

APA
Toishi Y, Tsunoda N, Kirisawa R. (2020). Period of excretion of equine herpesvirus 3 (EHV-3) from a stallion before showing clinical signs of equine coital exanthema and the effect of acyclovir treatment on the duration of EHV-3 excretion. J Vet Med Sci, 82(9), 1299-1305. https://doi.org/10.1292/jvms.20-0056

Publication

ISSN: 1347-7439
NlmUniqueID: 9105360
Country: Japan
Language: English
Volume: 82
Issue: 9
Pages: 1299-1305

Researcher Affiliations

Toishi, Yuko
  • Shadai Stallion Station, 275 Hayakita-Genbu, Abira-cho, Yufutsu-gun, Hokkaido 059-1432, Japan.
Tsunoda, Nobuo
  • Shadai Stallion Station, 275 Hayakita-Genbu, Abira-cho, Yufutsu-gun, Hokkaido 059-1432, Japan.
Kirisawa, Rikio
  • Laboratory of Veterinary Virology, Department of Pathobiology, School of Veterinary Medicine, Rakuno Gakuen University, 582 Bunkyoudai-Midorimachi, Ebetsu, Hokkaido 069-8501, Japan.

MeSH Terms

  • Acyclovir / therapeutic use
  • Animals
  • Exanthema / veterinary
  • Female
  • Herpesviridae Infections / drug therapy
  • Herpesviridae Infections / veterinary
  • Herpesvirus 1, Equid
  • Herpesvirus 3, Equid
  • Horse Diseases / drug therapy
  • Horses
  • Japan
  • Male

References

This article includes 21 references
  1. Allen GP, Umphenour NW. Equine coital exanthema. 2004. pp. 860–867. In: Infectious Diseases of Livestock (Coetzer, J. A. W. and Tustin, R. C. eds.), Oxford Press, Cape Town.
  2. Barrandeguy M, Thiry E. Equine coital exanthema and its potential economic implications for the equine industry.. Vet J 2012 Jan;191(1):35-40.
    doi: 10.1016/j.tvjl.2011.01.016pubmed: 21354835google scholar: lookup
  3. Barrandeguy M, Vissani A, Lezica FP, Salamone J, Heguy A, Becerra L, Olguin Perglione C, Thiry E. Subclinical infection and periodic shedding of equid herpesvirus 3.. Theriogenology 2010 Sep 1;74(4):576-80.
  4. Barrandeguy M, Vissani A, Olguin C, Barbara G, Valenzuela H, Becerra L, Tordoya M, Miño S, Thiry E. Experimental infection with equid herpesvirus 3 in seronegative and seropositive mares.. Vet Microbiol 2012 Dec 7;160(3-4):319-26.
    doi: 10.1016/j.vetmic.2012.06.024pubmed: 22776511google scholar: lookup
  5. Barrandeguy M, Vissani A, Olguin C, Becerra L, Miño S, Pereda A, Oriol J, Thiry E. Experimental reactivation of equine herpesvirus-3 following corticosteroid treatment.. Equine Vet J 2008 Sep;40(6):593-5.
    doi: 10.2746/042516408X333399pubmed: 19031515google scholar: lookup
  6. Burrows R, Goodridge D. Studies of persistent and latent equid herpesvirus 1 and herpesvirus 3 infections in the Pirbright pony herd. 1984. pp. 307–319. In: Latent Herpesvirus Virus Infections in Veterinary Medicine (Wittmann G., Gaskell RM and Rziha H.-J. eds.), Martinus Nijhoff, Boston.
  7. Bryans JT, Allen GP. In vivo and in vitro studies of equine ‘coital’ exanthema. 1973. pp. 322–336. In: Proceeding of the Third International Conference on Equine Infectious Diseases (Bryans JT and Gerber H. eds.), Karger, Basel.
  8. Cullinane A, McGing B, Naughton C. The use of acyclovir in the treatment of coital exanthema and ocular diseases caused by equid herpesvirus-3. 1994. p. 55. In: Equine Infectious Diseases VII (Nakajima H and Plowright W. eds.), R & W Publications, Newmarket.
  9. Dadarwal D, Palmer C, Griebel P. Mucosal immunity of the postpartum bovine genital tract.. Theriogenology 2017 Dec;104:62-71.
  10. Dynon K, Varrasso A, Ficorilli N, Holloway S, Reubel G, Li F, Hartley C, Studdert M, Drummer H. Identification of equine herpesvirus 3 (equine coital exanthema virus), equine gammaherpesviruses 2 and 5, equine adenoviruses 1 and 2, equine arteritis virus and equine rhinitis A virus by polymerase chain reaction.. Aust Vet J 2001 Oct;79(10):695-702.
  11. Ferreira C, Costa EA, França SA, De Melo UP, Drumond BP, Bomfim MRQ, Coelho FM, Resende M, Palhares MS, Santos RL. Equine coital exanthema in a stallion. Arq. Bras. Med. Vet. Zootec. 2010 626: 1517–1520.
  12. Hirai K, Nakajima K, Ikuta K, Kirisawa R, Kawakami Y, Mikami T, Kato S. Similarities and dissimilarities in the structure and expression of viral genomes of various virus strains immunologically related to Marek's disease virus.. Arch Virol 1986;89(1-4):113-30.
    doi: 10.1007/BF01309883pubmed: 2424404google scholar: lookup
  13. Kirisawa R, Terada M, Sekiya N, Kawakami Y, Iwai H. Growth and protective potentials of attenuated strains of equid herpesvirus 1 in the lungs of mice.. Zentralbl Veterinarmed B 1995 Sep;42(7):391-6.
  14. Kirisawa R, Toishi Y, Akamatsu A, Soejima K, Miyashita T, Tsunoda N. Isolation of equine herpesvirus 3 (EHV-3) from equine coital exanthema of two stallions and sero-epidemiology of EHV-3 infection in Japan.. J Vet Med Sci 2017 Mar 23;79(3):636-643.
    doi: 10.1292/jvms.16-0518pmc: PMC5383190pubmed: 28132964google scholar: lookup
  15. Kleiboeker SB, Chapman RK. Detection of equine herpesvirus 3 in equine skin lesions by polymerase chain reaction.. J Vet Diagn Invest 2004 Jan;16(1):74-9.
    doi: 10.1177/104063870401600113pubmed: 14974851google scholar: lookup
  16. Maxwell LK, Bentz BG, Bourne DW, Erkert RS. Pharmacokinetics of valacyclovir in the adult horse.. J Vet Pharmacol Ther 2008 Aug;31(4):312-20.
  17. Seki Y, Seimiya YM, Yaegashi G, Kumagai S, Sentsui H, Nishimori T, Ishihara R. Occurrence of equine coital exanthema in pastured draft horses and isolation of equine herpesvirus 3 from progenital lesions.. J Vet Med Sci 2004 Dec;66(12):1503-8.
    doi: 10.1292/jvms.66.1503pubmed: 15644599google scholar: lookup
  18. Toishi Y, Tsunoda N, Kirisawa R. Occurrence of equine coital exanthema (ECE) in stallions in Japan and effectiveness of treatment with valacyclovir for ECE.. J Vet Med Sci 2017 Mar 23;79(3):632-635.
    doi: 10.1292/jvms.16-0511pmc: PMC5383189pubmed: 28123140google scholar: lookup
  19. Velázquez MML, Peralta MB, Angeli E, Stassi AF, Gareis NC, Durante L, Cainelli S, Salvetti NR, Rey F, Ortega HH. Immune status during postpartum, peri-implantation and early pregnancy in cattle: An updated view.. Anim Reprod Sci 2019 Jul;206:1-10.
  20. Wilks CR, Studdert MJ. Equine herpesviruses. 6. Sequential infection of horses with types 2, 3 and 1.. Aust Vet J 1976 May;52(5):199-203.
  21. Wood JNW, Cardwell JM, Castillo-Olivares J, Irwin V. Transmission of diseases thorough semen. 2007. pp. 266–274. In: Current Therapy in Equine Reproduction (Samper JC, Pycock JF and McKinnon AO eds.), Saunders Elsevier, Amsterdam.

Citations

This article has been cited 1 times.
  1. Vissani MA, Damiani AM, Barrandeguy ME. Equine Coital Exanthema: New Insights on the Knowledge and Leading Perspectives for Treatment and Prevention.. Pathogens 2021 Aug 20;10(8).
    doi: 10.3390/pathogens10081055pubmed: 34451519google scholar: lookup